← Back to Search

Neuromodulation Device

Spinal Cord Neuromodulation for Spinal Cord Injury

Phase 1 & 2
Waitlist Available
Led By Daniel C Lu, MD PhD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No coagulopathy, cardiac risk factors, or other significant medical risk factors for surgery
Non-progressive SCI above C5
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

Study Summary

This trial will test if a spinal cord stimulator can help people with spinal cord injuries to move better.

Who is the study for?
This trial is for adults over 18 with non-progressive spinal cord injury above C5, at least one year post-injury. Participants should not have severe heart/lung diseases, ongoing depression or drug abuse, recent botox injections, or conditions that prevent arm movement. Pregnant women and those on anti-spasticity meds or involved in other trials are excluded.Check my eligibility
What is being tested?
The study tests whether spinal cord stimulation combined with a medication called Buspirone can improve movement in people with quadriplegia due to spinal cord injury. It aims to assess the effectiveness of this neuromodulation strategy.See study design
What are the potential side effects?
Potential side effects may include discomfort from the epidural stimulation device and common reactions to Buspirone like dizziness, nausea, headache, fatigue, and restlessness.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I don't have bleeding disorders, heart risks, or major health issues for surgery.
Select...
My spinal cord injury is stable and located above the C5 vertebra.
Select...
My reflexes work below my spinal injury.
Select...
I am not pregnant and use birth control.
Select...
I do not have severe heart or lung diseases.
Select...
I am not currently taking any medication for muscle stiffness.
Select...
It has been over a year since my injury.
Select...
I don't have any unhealed injuries or infections in my arms that would affect training.
Select...
I am 18 years old or older.
Select...
My heart and lungs are healthy enough for me to move my hands and arms without issues.
Select...
I do not have severe heart or lung diseases.
Select...
I cannot grip or move on my own.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Assessment of arm/hand function

Trial Design

1Treatment groups
Experimental Treatment
Group I: StimulationExperimental Treatment2 Interventions
Determine if epidural stimulation can improve motor function.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Buspirone
2022
Completed Phase 4
~1160

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,528 Previous Clinical Trials
10,276,839 Total Patients Enrolled
1 Trials studying Quadriplegia
2 Patients Enrolled for Quadriplegia
Daniel C Lu, MD PhDPrincipal InvestigatorUniversity of California, Los Angeles

Media Library

Epidural Stimulation (Neuromodulation Device) Clinical Trial Eligibility Overview. Trial Name: NCT02313194 — Phase 1 & 2
Quadriplegia Research Study Groups: Stimulation
Quadriplegia Clinical Trial 2023: Epidural Stimulation Highlights & Side Effects. Trial Name: NCT02313194 — Phase 1 & 2
Epidural Stimulation (Neuromodulation Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02313194 — Phase 1 & 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the cumulative figure of participants engaging in this research project?

"This trial is no longer taking partipants. It was published on July 1st 2013 and last updated November 23rd 2021. Nonetheless, there are 363 trials involving quadriplegia currently recruiting participants and 9 trials based around epidural stimulation actively enrolling volunteers."

Answered by AI

Is recruitment for this research endeavor still in process?

"Based on the information available via clinicaltrials.gov, recruitment has ceased for this particular study which was first posted in July 2013 and most recently updated in November 2021. Although no longer recruiting, there are 372 other trials that have open enrolments right now."

Answered by AI

Have there been any reviews of Epidural Stimulation in the past?

"Nine clinical trials concerning Epidural Stimulation are currently in progress, though none of them have advanced to Phase 3. Lexington, Massachusetts is the predominant research hub for this treatment; nevertheless, there are nine additional sites conducting experiments."

Answered by AI

Who else is applying?

What state do they live in?
Georgia
California
How old are they?
65+
18 - 65
What site did they apply to?
UCLA
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria

Why did patients apply to this trial?

I am always seeking ways to improve my independence and overall condition.
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
Spinal Cord Neuromodulation for Spinal Cord Injury
Daniel Lu, MD, PhD 2013. "Spinal Cord Neuromodulation for Spinal Cord Injury". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02313194.
All > Spinal Cord
~1 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top